delivery platforms

MicroDose Therapeutx has developed three core technology platforms spanning pulmonary, solid oral dosage, and transdermal drug delivery. Each platform technology is supported by in-depth technical know-how and a portfolio of both issued and pending patents, and each can be applied across a broad range of disease states and therapeutic candidates.

MicroDose’s delivery platforms include:

• Dry Powder Inhalation;
• Fixed-Dose-Combination Oral Dosage in PolyCap™; and
• Needlefree Transdermal Systems.